Economic evaluation of the fixed combination of insulin glargine and lixisenatide in Diabetes Mellitus type 2

• Main Authors: S. V. Nedogoda (Author), A. S. Salasyuk (Author), I. N. Barikina (Author), V. O. Smirnova (Author), M. Yu. Frolov (Author)
• Formato: Libro
• Publicado: Izdatelstvo OKI, 2020-01-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Aim: a prognosis of clinical-economic efficacy of the fixed combination of insulin glargine and lixisenatide (Soliqua SoloStar®) in comparison with standard therapy with focus on micro- and macrovascular complications of Diabetes Mellitus type 2 (T2DM) in the real practice.Materials and Methods. Mod...